Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based⦠read more
Healthcare
Biotechnology
2 years
USD
Exclusive to Premium users
$3.19
Price+11.02%
$0.32
$865.849m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$215.853m
-
1y CAGR-
3y CAGR-
5y CAGR-$194.719m
-
1y CAGR-
3y CAGR-
5y CAGR-$1.36
-
1y CAGR-
3y CAGR-
5y CAGR$467.983m
$896.966m
Assets$428.983m
Liabilities$371.079m
Debt41.4%
-1.3x
Debt to EBITDA-$44.206m
-
1y CAGR-
3y CAGR-
5y CAGR